ArticleTranslational behavioral medicine2011
Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation.
Article in Translational behavioral medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03194958 (Helping the Poor Quit Smoking), which is not on this map. Cited by 13 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Helping the Poor Quit Smoking: Specialized Quitlines and Meeting Basic Needs
Who cites it
13 citing papers in PubMed, 4 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- Behavioural interventions for smoking cessation: an overview and network meta-analysis.The Cochrane database of systematic reviews · 2021Pooled it
- Telephone counselling for smoking cessation.The Cochrane database of systematic reviews · 2019Pooled it
- Internet-based interventions for smoking cessation.The Cochrane database of systematic reviews · 2017Pooled it
- Medical costs and quality-adjusted life years associated with smoking: a systematic review.BMC public health · 2016Pooled it
- Cost-Effectiveness of a Comprehensive Primary Care Smoking Treatment Program.American journal of preventive medicine · 2024Trial
- Financial incentives to Medicaid smokers for engaging tobacco quit line treatment: maximising return on investment.Tobacco control · 2020Trial
- Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2019Trial
- Evaluation of a population-level strategy to promote tobacco treatment use among insured smokers: a pragmatic, randomized trial.BMC public health · 2018Trial
- Trial
- Cost-effectiveness of internet and telephone treatment for smoking cessation: an economic evaluation of The iQUITT Study.Tobacco control · 2013Trial
- Cost-Effectiveness of a Health System-Based Smoking Cessation Program.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017Article
- The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.Tobacco use insights · 2015Review
- Early diagnosis of lung cancer.F1000prime reports · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
Abstract
There is a lack of evidence of the relative cost-effectiveness of proactive telephone counseling (PTC) and Web-based delivery of smoking cessation services in conjunction with pharmacotherapy. We calculated the differential cost-effectiveness of three behavioral smoking cessation modalities with varenicline treatment in a randomized trial of current smokers from a large health system. Eligible participants were randomized to one of three smoking cessation interventions: Web-based counseling (n=401), PTC (n=402), or combined PTC-Web counseling (n=399). All participants received a standard 12-week course of varenicline. The primary outcome was a 7-day point prevalent nonsmoking at the 6month follow-up. The Web intervention was the least expensive followed by the PTC and PTC-Web groups. Costs per additional 6-month nonsmoker and per additional lifetime quitter were $1,278 and $2,601 for Web, $1,472 and $2,995 for PTC, and $1,617 and $3,291 for PTC-Web. Cost per life-year (LY) and quality-adjusted life-year (QALY) saved were $1,148 and $1,136 for Web, $1,320 and $1,308 for PTC, and $1,450 and $1,437 for PTC-Web. Based on the cost per LY and QALY saved, these interventions are among the most cost-effective life-saving medical treatments. Web, PTC, and combined PTC-Web treatments were all highly cost-effective, with the Web treatment being marginally more cost-effective than the PTC or combined PTC-Web treatments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.